Golden Tiger Pain Relief Cream Recalled for Out-of-Specification Active Ingredient
ARG Laboratories is recalling Golden Tiger Natural Pain Relieving Cream nationwide due to the active ingredient being out of specification and improper grade propylene glycol being used during manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a topical drug product with manufacturing defects affecting active ingredient specification and ingredient quality. No illnesses or injuries have been reported; however, the out-of-specification active ingredient and use of violative-grade propylene glycol in a product applied directly to skin constitutes a risk-of-harm product without reported injury, warranting a High severity classification.
Plain-English summary
ARG Laboratories, Inc. is recalling Golden Tiger Natural Pain Relieving Cream distributed nationwide. The product is a topical pain relief preparation available in 3 fl oz roll-on bottles and contains 3% Camphor, 3% Menthol, and botanical ingredients including Capsaicin, Aloe Vera, Willow Bark, and MSM.
The recall was initiated because testing found the active ingredient to be out of specification and because a violative grade of propylene glycol was used during the manufacturing process. Propylene glycol is commonly used as a carrier ingredient in topical preparations.
The affected product is identified by Lot 17323C3, which has an expiration date of 06/30/2025. Consumers who have this product should stop using it immediately. Questions about the recall can be directed to ARG Laboratories, Inc. or the U.S. Food and Drug Administration.
The recalled product
- Product
- NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Roll-On NET WT 3 fl. oz. (88.7ml), Manufactured for Golden Tiger USA Albuquerque, NM, UPC 1 82294 00006 2
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical Analgesic
- Hazard
- active-ingredient-out-of-spec
- improper-ingredient-grade
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 17323C3
- Exp 06/30/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- HighLacosamide 100mg Tablets Recalled Due to Foreign Tablet Contamination
FDA (Drugs) · 2026-07-01
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01